Isomorphic Labs is in advanced discussions to raise more than $2 billion in new funding. Thrive Capital is expected to lead the financing for the Alphabet-owned drug discovery firm.
The startup spun out of Google DeepMind to leverage AlphaFold protein prediction technology. The company previously raised $600 million in March 2025.
The deal size reflects high investor demand for AI-driven medical development.